Ages 2+Control-IQ+ Technology

Easy to start, easy to use, easy to personalize. See how easy control can be with Tandem.

Control-IQ+ technology, which supports pump users as young as 2 years old, uses CGM sensor* values to predict glucose levels 30 minutes ahead and automatically adjust insulin delivery.

Helps Prevent Highs

Control-IQ+ can increase basal insulin and can deliver an AutoBolus^† if the sensor glucose value is predicted to be high.

Helps Prevent Lows

Control-IQ+ can decrease or stop basal insulin if sensor glucose is predicted to be low. This can help improve time in range.

Easy-to-Follow

Icons on the pump screen indicate whether insulin dosing is increasing, decreasing, or being stopped by Control-IQ+ technology.

Activity Settings

Settings for sleep and exercise use a narrower treatment range, adapting to changes in activity.

Best-in-Class Outcomes

Amount of time real-world users spent in range between the hours of 4 am and 7 am with Control-IQ+.¹

Average reduction in A1c levels for real-world users of Control-IQ+ technology, even with occasional bolus use.²

Increase in average time spent in range on the first day of using the t:slim X2 pump with Control-IQ+.¹

Additional Features

Temp Basal Rate

Allows users to temporarily increase or decrease their basal insulin delivery when using Control-IQ+. This can be beneficial to manage blood sugar during illness or stress.

Extended Bolus

Delivers insulin gradually over time, up to 8 hours, instead of immediately. Helps users better manage meals high in fat or protein and conditions requiring prolonged insulin action.

Tandem pump user, Colby (diagnosed 2007), and the Tandem t:slim X2 and Mobi insulin pumps shown below

Trusted: Control-IQ+ has 440,000+ users worldwide with 300+ million patient days!³

My [HbA1c] has been amazing since I switched to Tandem. I used to wake up with lows, and that’s scary. But Tandem is my safety net. I don’t worry about overnight lows anymore. Izzy, diagnosed 2016

Note: Individual symptoms, situations, circumstances, and results may vary.

* CGM sold separately.
† If glucose values are predicted to be above 10.0 mmol/L (180 mg/dL) Control-IQ technology calculates an AutoBolus using the Personal Profile settings and a target of 6.1 mmol/L (110 mg/dL) and delivers 60% of that value.

References

Note: Studies were conducted using a t:slim X2 insulin pump with Control-IQ technology and a Dexcom G6 sensor.
1. Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.
2. Akturk HK, et al. Diabetes Technol Ther. 2022;24(10):779-783.
3. As of April, 2026. Data on file, Tandem Diabetes Care.

Important Safety Information

Always read the label and follow the instructions: tandemdiabetes.com/safetyinfo